<DOC>
	<DOCNO>NCT00748319</DOCNO>
	<brief_summary>The frequent cutaneous T-cell lymphoma ( CTCL ) mycosis fungoid Sezary syndrome . The diagnosis lymphoma difficult use current method , especially numerous benign dermatological condition mimick CTCL clinically microscopic examination . Recently , KIR receptor CD158k show marker Sezary syndrome blood skin . We hypothesize receptor family may help fro diagnosis lymphoma . To address issue , study expression know KIR receptor skin patient present skin eruption , may correspond either cutaneous T-cell lymphoma benign dermatological disease . The final diagnosis establish panel expert , allow constitution 2 group patient : cutaneous T-cell lymphoma group , benign inflammatory disease group . The expression different KIRs analyze group blind fashion , order determine whether one several KIRs may differentially express .</brief_summary>
	<brief_title>Killer Immunoglobulin-Like Receptor Transcripts Expression Diagnosis Epidermotropic Cutaneous T Cell Lymphoma</brief_title>
	<detailed_description>Background : The frequent cutaneous T-cell lymphoma ( CTCL ) mycosis fungoid Sezary syndrome . Both due proliferation CD4+ T-cell clone skin , associate blood involvement Sezary syndrome . Mycosis fungoid clinically present patch plaque dermatitis Sezary syndrome exfoliative dermatitis . The diagnosis lymphoma difficult use current method , especially numerous benign dermatological inflammatory condition mimick CTCL clinically microscopic examination . Recently , KIR receptor CD158k show marker Sezary syndrome blood skin . We hypothesize receptor family may help fro diagnosis lymphoma . Aim study : determine one panel KIR ( ) receptor ( ) may help differential diagnosis cutaneous T-cell lymphoma ( CTCL ) benign inflammatory dermatosis . Subjects selection : patient present investigator , member GFELC expert group ( `` French Group Study Cutaneous Lymphoma '' ) , either exfoliative patch/plaque dermatitis clinical suspicion CTCL enrol . Number subject : A total 550 patient could recruit GFELC , include 180 CTCL ( 60 Sezary syndrome 120 mycosis fungoid ) 370 inflammatory disease ( 240 patch dermatitis 130 exfoliative dermatitis ) . Inclusion period : patient include 2 year period follow 6 month . Total study length 30 month . Interventions : 1 ) 3 mm punch skin biopsy patient 2 ) 10 ml blood sample patient exfoliative dermatitis Methods : Following initial 6 month follow-up evaluation , patient classify one follow group : cutaneous T-cell lymphoma group , benign inflammatory disease group . The expression know KIRs receptor ( KIR2DL1 ( CD158a ) , KIR2DL2 ( CD158b1 ) , KIR2DL3 ( CD158b2 ) , KIR2DL4 ( CD158d ) , KIR2DL5 ( CD158f ) , KIR3DL1 ( CD158e1 ) , KIR3DL2 ( CD158k ) , KIR2DS1 ( CD158h ) , KIR2DS2 ( CD158j ) , KIR2DS4 ( CD158i ) , KIR2DS5 ( CD158g ) , KIR3DS1 ( CD158e2 ) ) evaluate use reverse transcription quantitative polymerase chain reaction skin blood sample , blind fashion . For blood sample , analysis perform CD4+ T-cell sort use magnetic bead . Outcome measure : The main outcome measure differential expression one panel KIR ( ) receptor ( ) CTCL benign inflammatory disease . Secondary outcome measure differential quantitative expression one panel KIR ( ) receptor ( ) two group .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Sezary Syndrome</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Dermatitis , Exfoliative</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Signed consent Subacute/chronic dermatitis ( &gt; 7 day ) clinical suspicion cutaneous Tcell lymphoma No past history lymphoma hematologic malignancy Skin biopsy routine histology inclusion Cutaneous Tcell clonality analysis inclusion Sezary cell count routine blood smear examination case erythroderma Blood Tcell clonality analysis inclusion case erythroderma Age &lt; 18 year Skin biopsy routine histology inclusion ( Possibility , 6 previous month inclusion without specific treatment taht local corticoid amendment n째4 ) Cutaneous Tcell clonality analysis inclusion ( Possibility , 6 previous month inclusion without specific treatment taht local corticoid amendment n째4 ) Realization preliminary medical examination Sezary cell count routine blood smear examination case erythroderma ( Possibility , 6 previous month inclusion without specific treatment taht local corticoid amendment n째4 ) Blood Tcell clonality analysis inclusion case erythroderma ( Possibility , 6 previous month inclusion without specific treatment taht local corticoid amendment n째4 ) Adults tutelage Subject affiliate French National health pension organization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Receptors KIR</keyword>
	<keyword>Polymerase chain reaction</keyword>
	<keyword>Diagnosis</keyword>
	<keyword>Lymphoma T-cell cutaneous</keyword>
	<keyword>Mycosis fungicide</keyword>
	<keyword>Sezary syndrome</keyword>
	<keyword>Differential diagnosis dermatitis</keyword>
</DOC>